http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114532530-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7406357c5e5262c1fee58fbfcc3f74a3 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-19 |
| filingDate | 2022-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0814b1d99a9af3942681ff5bdf21431 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34738d06739985ea6cae7ad819d8ca50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f73272b73ffe5fe4f7f4ddd063db8e9 |
| publicationDate | 2022-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114532530-A |
| titleOfInvention | A kind of colostrum glucosamine chondroitin calcium chewable tablet and preparation method thereof |
| abstract | The invention discloses a colostrum glucosamine chondroitin calcium chewable tablet, which comprises main materials and auxiliary materials, and the mass ratio of the main materials and auxiliary materials is 9-10:5.4-5.7; the main materials include: glucosamine hydrochloride, citric acid Calcium, chondroitin sulfate, colostrum basic protein powder, puerarin, ferulic acid, Dendrobium officinale extract, glucosamine hydrochloride, calcium citrate, chondroitin sulfate, colostrum basic protein powder, puerarin, The mass ratio of salicylic acid and Dendrobium officinale extract is 250‑260: 500‑530: 140‑160: 20‑30: 1‑10: 1‑5: 1‑5; excipients include: mannitol, lactose, emulsifier, Magnesium stearate. The invention discloses a preparation method of the above colostrum glucosamine chondroitin calcium chewable tablet. The invention adopts ferulic acid, puerarin, Dendrobium officinale extract and other raw materials to produce synergistic effect, regulates the activity of osteoblasts and osteoclasts, promotes bone resorption and bone formation, maintains bone homeostasis, and significantly increases bone density. Thereby improving the symptoms of osteoporosis. |
| priorityDate | 2022-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 161.